Asia·Aug 23, 2026
Celltrion Launches IV Version of SteQeyma in Japan's Growing Biologics Market
South Korean biotech adds Crohn's disease indication to autoimmune treatment four months after regulatory approval
By Cheng Wei-Lun · 3 min ·
Every BriefAsia story tagged Celltrion, newest first.

South Korean biotech adds Crohn's disease indication to autoimmune treatment four months after regulatory approval

Korean biopharma's Q2 profit jumped 86% on stronger biosimilar demand, pushing operating margin past 32% for the first time